Avalo Therapeutics (AVTX) vs Collegium Pharmaceutical (COLL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Avalo Therapeutics (AVTX) has outperformed Collegium Pharmaceutical (COLL) over the past year, gaining 0.7% versus a loss of 34.3%. Over five years, COLL leads with a +4.5% price change compared with -99.8% for AVTX. Avalo Therapeutics is the larger company by market cap ($728.3 million vs $713.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVTX | COLL |
|---|---|---|
| Share price | $13.58 | $21.93 |
| Market cap | $728.30M | $713.94M |
| 1-day change | -0.07% | +0.23% |
| YTD return | -25.22% | -52.63% |
| 1-year return | +0.74% | -34.32% |
| 5-year return | -99.79% | +4.53% |
| P/E ratio (TTM) | — | 17.27 |
| Forward P/E | — | 3.30 |
| EPS (TTM) | $-4.31 | $1.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.27 | $50.79 |
| 52-week low | $12.51 | $21.43 |
| Distance from 52-week high | -44.05% | -56.82% |
| Average volume | 929.44K | 747.73K |
| Shares outstanding | 53.63M | 32.56M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AVTX has outperformed COLL by 35.1 percentage points over the past year.
AVTX vs COLL FAQ
Which is bigger, Avalo Therapeutics or Collegium Pharmaceutical?
Avalo Therapeutics (AVTX) is larger, with a market capitalization of $728.30M compared with $713.94M for Collegium Pharmaceutical (COLL).
Which stock has performed better over the past year, AVTX or COLL?
AVTX returned +0.74% over the past 12 months, compared with -34.32% for COLL (price return, excluding dividends). Past performance does not predict future results.
Are Avalo Therapeutics and Collegium Pharmaceutical in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.